HIK — Hikma Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- £3.11bn
- £4.17bn
- $3.35bn
UK's Hikma Pharmaceuticals reiterates 2026 outlook despite higher costs from Iran war
Brief: Hikma Says Demand In Middle East Region Remains Robust & Group Continues To Maintain Sufficient Inventory Levels
Hikma Pharmaceutical - Trading Statement
UK Stocks-Factors to watch on April 23
Hikma Pharmaceutical - Director/PDMR Shareholding
Hikma Pharmaceutical - Director/PDMR Shareholding
Press Digest: British Business - March 30
Hikma Pharmaceutical - Annual Financial Report and Notice of AGM
Europe Research Roundup: Epiroc , Neste , Wacker Chemie
Hikma Pharmaceutical - Director/PDMR Shareholding
IG Group, Lion Finance to enter FTSE 100; Easyjet, Hikma dropped
Europe Research Roundup: Danone, Emeis, Sandoz Group
Europe Research Roundup: Aixtron, Ferrari, Orsted
Live Markets: Markets still underpricing public-private nuclear push - WisdomTree
Live Markets: To survive a fractured world, ditch the old rulebook
Live Markets: Utilities and industrials keep STOXX high
UK's Hikma shares plunge on weak sales forecast
UK's Hikma warns of slower sales growth, withdraws medium-term outlook (updated)
UK Stocks-Factors to watch on February 26 (updated)